Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$735,795
+$37,870 QoQ
Shares Held
2,924
-8.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#2,838
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alhambra Investment Management LLC holds $9,363,953 across 10 Drug Manufacturers - General names. ABBV ranks #6 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
8,705 | $2,210,808 | |
| 2 | AMGN |
Amgen Inc
|
4,329 | $1,567,617 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,112 | $1,299,392 | |
| 4 | LLY |
ELI LILLY & Co
|
1,067 | $1,279,791 | |
| 5 | NVS |
Novartis AG
|
5,321 | $833,907 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
2,924 | $735,795 | |
| 7 | AZN |
Astrazeneca PLC
|
2,840 | $538,520 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,185 | $413,999 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $735,795 | 2,924 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $697,925 | 3,209 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $723,627 | 3,167 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $840,027 | 3,628 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $729,300 | 3,929 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $732,691 | 3,497 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $621,061 | 3,495 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $619,099 | 3,135 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $537,029 | 3,131 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $469,089 | 2,576 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $416,714 | 2,689 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $411,852 | 2,763 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $381,555 | 2,832 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $457,551 | 2,871 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $443,781 | 2,746 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $370,016 | 2,757 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $422,108 | 2,756 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $450,665 | 2,780 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $489,471 | 3,615 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $440,217 | 4,081 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $459,683 | 4,081 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $440,671 | 4,072 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $410,813 | 3,834 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $339,236 | 3,873 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $283,642 | 2,889 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||